FDA panel supports broadening access to peptides popular on the gray market

Shouldn’t we just call them unlicensed and untested injectable drugs? “Peptides” is both excessively broad and insufficiently informative. The purpose of these injections is to cause the body to behave differently. That’s what a drug does. These concoctions haven’t been tested and approved. Giving them a new name gives the public the impression they’re a new thing. They are not. They are an old thing: an untested drug.